Novanta Inc.
Financials
Valuation Metrics
Novanta Inc.'s Market Cap is $5.28B. At end of 2025 it was $4.55B. Ranked #1348 of 3,112 in US market (top 43%), #456 of 1,445 on NASDAQ (top 32%), #53 of 99 in Technology Hardware & Equipment (top 54%) by Market Cap.
Investment Metrics(as of 2026-08-03)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | $5.28B | US#1,348/3,112 Sec#53/99 |
| Revenue | $1.00B | US#1,938/3,112 Sec#64/99 |
| Net Income | $54M | US#1,833/3,112 Sec#61/99 |
| Total Assets | $1.80B | US#2,127/3,112 Sec#62/99 |
| Net Assets | $1.31B | US#1,576/3,112 Sec#55/99 |
| Employees | 3,000 | US#997/3,112 Sec#47/99 |
| Value | ||
| P/E | 98.34x | US#2,048/3,112 Sec#67/99 |
| P/B | 4.03x | US#1,985/3,112 Sec#49/99 |
| P/S | 5.26x | US#2,310/3,112 Sec#64/99 |
| EV/EBITDA | 34.61x | US#2,236/3,112 Sec#71/99 |
| FCF Yield | 1.27% | US#2,093/3,112 Sec#69/99 |
| Profitability | ||
| ROE | 4.10% | US#1,910/3,112 Sec#64/99 |
| ROA | 2.99% | US#1,397/3,112 Sec#56/99 |
| Op. Margin | 11.63% | US#1,493/3,112 Sec#40/99 |
| Revenue Growth | 10.43% | US#1,269/3,112 Sec#62/99 |
| Earnings Growth | -0.51% | US#1,398/3,112 Sec#49/99 |
| Financial Health | ||
| Debt Ratio | 37.22% | US#425/3,112 Sec#20/99 |
| Total Debt | $290M | US#2,048/3,112 Sec#46/99 |
| FCF | $67M | US#1,823/3,112 Sec#57/99 |
| Cash | $389M | US#1,250/3,112 Sec#46/99 |
| Current Ratio | 3.56x | US#652/3,112 Sec#19/99 |
| Net Debt/EBITDA | -0.66x | US#397/3,112 Sec#22/99 |
| Performance | ||
| 1Y Return | 23.51% | US#1,482/3,112 Sec#64/99 |
| 1M Return | -8.27% | US#2,498/3,112 Sec#72/99 |
| From 52W High | -13.68% | US#1,322/3,112 Sec#29/99 |
| 1Y MDD | -26.97% | US#1,150/3,112 Sec#24/99 |
| Trading | ||
| Volume | 375,843 shares | US#2,265/3,112 Sec#74/99 |
| Trading Value | $55M | US#1,293/3,112 Sec#60/99 |
| Per Share | ||
| EPS | $1.41 | US#1,473/3,112 Sec#51/99 |
| BPS | $34.37 | US#740/3,112 Sec#26/99 |
Company Info
Novanta Inc., together with its subsidiaries, provides precision medicine, precision manufacturing, medical solutions, robotics and automation solutions, and advanced surgery solutions in the United States and internationally. The company operates Automation Enabling Technologies and Medical Solutions segments. The Precision Medicine and Manufacturing segment designs, manufactures, and markets laser beam steering and scanning solutions, laser sources, robotic and precision motion, robotic end-of-arm tooling, and bearing spindles. This segment serves advanced industrial processes, advanced industrial and medical robotics, other medical and life science automation applications, and medical laser procedures, such as ophthalmology applications. The Medical Solutions segment provides a range of medical grade technologies, including medical insufflators, pumps, and related disposables; imaging, identification and RFID solutions; advanced motion control solutions; and light engines, and integrated operating room technologies. The company was formerly known as GSI Group, Inc. and changed its name to Novanta Inc. in May 2016. Novanta Inc. was incorporated in 1968 and is based in Bedford, Massachusetts.